The prevention strategy of HIV transmission to new offspring includes prescribing several ARTs and other drugs to an expectant mother. The new study emerged stating that mother’s exposure to one of the drugs Tenofovir Disoproxil Fumarate is linked to lower bone mass in newborns. Several drugs are used in the management of HIV in infected patients. Sometimes, the HIV-infected patients may become expectant. In this situation, comprehensive drug treatment procedure may result in healthy and uninfected newborn.
However, the effects of these drugs on the newborns have yet to be fully studied. One such drug is Tenofovir Disoproxil Fumarate, an antiretroviral drug. It is a drug prescribed to adults and pediatric patients over 2 years in the cases of HIV-1 and hepatitis B infection. In the treatment of infected expectant mothers, the drug is continually prescribed in the third trimester. The…
